Companies in #Ultra-Rare Genetic Disorders

Beren Therapeutics is a private late-stage rare-disease biotechnology company developing precision therapies for ultra-rare genetic disorders, with a lead program approaching an FDA filing. The company leverages patient-specific genetic insights to develop targeted small-molecule and antisense therapies.